LONCEF-CV325

Loncef–CV 325 Tablets (Cefpodoxime Proxetil & Potassium Clavulanate) – Broad Spectrum Antibiotic Protection

Loncef–CV 325 Tablets combine Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic, with Potassium Clavulanate, a beta-lactamase inhibitor that enhances antibiotic effectiveness by preventing bacterial resistance.

This powerful combination is widely used in the treatment of respiratory tract infections, urinary tract infections, ENT infections, skin and soft tissue infections, and other bacterial conditions. Cefpodoxime works by inhibiting bacterial cell wall synthesis, while Clavulanate protects it from degradation by beta-lactamase–producing bacteria, ensuring broader coverage and improved efficacy.

Key Benefits:

• Broad-spectrum antibacterial coverage

• Effective against resistant bacteria

• Suitable for respiratory, urinary, and ENT infections

• Helps in faster recovery from bacterial infections

• Reliable dual-action antibiotic therapy

Composition:
Cefpodoxime Proxetil & Potassium Clavulanate

Dosage Form: Tablets
Category: Antibiotic (Cephalosporin + Beta-lactamase inhibitor)
Indication: Bacterial infections (as directed by physician)